Dehdari Vais R, Yadegari H, Heli H, Sattarahmady N. A β-Amyloid
(1-42) Biosensor Based on Molecularly Imprinted Poly-Pyrrole for Early Diagnosis of Alzheimer's Disease.
J Biomed Phys Eng 2021;
11:215-228. [PMID:
33937128 PMCID:
PMC8064131 DOI:
10.31661/jbpe.v0i0.1070]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2018] [Accepted: 01/23/2019] [Indexed: 11/16/2022]
Abstract
Background:
Alzheimer’s disease (AD) is a common form of dementia, characterized by production and deposition of β-amyloid peptide in the brain.
Thus, β-amyloid peptide is a potentially promising biomarker used to diagnose and monitor the progression of AD.
Objective:
The study aims to develop a biosensor based on a molecularly imprinted poly-pyrrole for detection of β-amyloid.
Material and Methods:
In this experimental study, an imprinted poly-pyrrole was employed as an artificial receptor synthesized by electro-polymerization of pyrrole
on screen-printed carbon electrodes in the presence of β-amyloid. β-amyloid acts as a molecular template within the polymer. The biosensor was
evaluated by cyclic voltammetry using ferro/ferricyanide marker. The parameters influencing the biosensor performance, including electro-polymerization
cycle umbers and β-amyloid binding time were optimized to achieve the best biosensor sensitivity.
Results:
The β-amyloid binding affinity with the biosensor surface was evaluated by the Freundlich isotherm, and Freundlich
constant and exponent were obtained as 0.22 ng mL-1 and 10.60, respectively. The biosensor demonstrated a detection limit of 1.2 pg mL-1.
The biosensor was applied for β-amyloid determination in artificial cerebrospinal fluid.
Conclusion:
The biosensor is applicable for early Alzheimer’s disease detection.
Collapse